Effectiveness of Novomix insulin versus NPH insulin in diabetic patients in Iran.
Not Applicable
- Conditions
- Diabetes mellitus.Insulin-dependent diabetes mellitus and Non-insulin-dependent diabetes mellitusE10, E11
- Registration Number
- IRCT201112038282N1
- Lead Sponsor
- Tehran Univeristy of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Male or female patients with type 1 and 2 diabetes; diabetic patients who are inadequately controlled blood glucose on their previous therapy that have HbA1c< 10%; diabetic patients who are administrated with Novomix or NPH.
Exclusion criteria:Patients occurrence of sever side–effects; suffering from diabetes in pregnancy; any refuse to participate in study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c. Timepoint: every 3 months. Method of measurement: laboratory tests.
- Secondary Outcome Measures
Name Time Method Costs of treatments. Timepoint: At the end of the study. Method of measurement: Economic evaluations.